©The Author(s) 2025.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 112063
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.112063
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.112063
Table 1 Participants’ baseline characteristics
| Age (years) | Male | Illness duration (d) | BMI (kg/m2) | Family history | |
| ACET group (n = 40) | 34.23 ± 8.08 | 22 (55.00) | 15.45 ± 8.71 | 31.00 ± 4.37 | 4 (10.00) |
| Control group (n = 40) | 38.38 ± 12.15 | 25 (62.50) | 14.15 ± 6.52 | 29.95 ± 3.75 | 3 (7.50) |
| t/χ2 | 1.799 | 0.464 | 0.756 | 1.153 | 0.157 |
| P value | 0.076 | 0.496 | 0.452 | 0.252 | 0.692 |
- Citation: Hu QH, Liu W, Yin HQ, Wang YF, Zhang WK, Shen ML. Efficacy of acupoint catgut embedding therapy for phlegm-turbidity and blood-stasis metabolic dysfunction-associated fatty liver disease. World J Gastrointest Surg 2025; 17(12): 112063
- URL: https://www.wjgnet.com/1948-9366/full/v17/i12/112063.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i12.112063